425: Strive & Semler Scientific Merger: Cautionary Update

Strive, Inc. filed a Form 425 providing cautionary statements and procedural details regarding its proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. filed a Form 425 related to its proposed business combination with Semler Scientific, Inc.
• The communication was reposted on X.com by Pierre Rochard, a Strive Board Member, on December 18, 2025.
• The filing includes extensive cautionary statements regarding forward-looking statements related to the merger.
• It details where investors can find additional information, including the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus.
• Strive and Semler Scientific, along with their directors and executive officers, may be deemed participants in the solicitation of proxies for the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement for a proposed business combination, detailing numerous risks and procedural information. It does not present new positive or negative operational news, but rather outlines potential challenges inherent in such transactions, leading to a neutral sentiment.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the realization of anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could also harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The filing contains forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of closing, and the ability to successfully integrate businesses. However, it heavily cautions that actual results may differ materially from anticipated results due to various risks and uncertainties.

Management Comments

• Pierre Rochard, a Board Member of Strive, Inc., reposted the communication on X.com on December 18, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

This filing is a standard procedural and cautionary document for a proposed merger, a common strategic move in various industries. The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a strategic direction for the combined entity that aligns with a growing trend of corporate adoption of digital assets, particularly Bitcoin, as part of treasury management or broader strategic initiatives.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Dilution for existing Strive shareholders due to the issuance of new Class A common stock in connection with the proposed transaction.

Next Steps

• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus regarding the proposed transaction and any other relevant documents filed with the SEC before making any voting or investment decision.
• Strive and Semler Scientific may file with the SEC any other relevant documents concerning the proposed transaction.
• A definitive Information Statement/Proxy Statement/Prospectus was sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Corporate Governance, Risk Factors, Bitcoin, Digital Assets